NewAmsterdam Pharma Company N.V. (NAMS) vs Privia Health Group, Inc. (PRVA)
A side-by-side comparison of NewAmsterdam Pharma Company N.V. and Privia Health Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NAMS
NewAmsterdam Pharma Company N.V.
$22.10HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
PRVA
Privia Health Group, Inc.
$20.51HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
Total return — NAMS vs PRVA
growth of $100 · dividends reinvested · last 5yNAMS +130.3% (+18.2%/yr)PRVA -11.1% (-2.3%/yr)NAMS compounded faster over this window
NAMS PRVA
NAMS vs PRVA: by the numbers
- •PRVA is the larger company ($2.58B vs $2.58B market cap).
- •PRVA is profitable (1.19% net margin) while NAMS runs a net loss (-3644.21%).
Metrics side by side
Valuation
| Metric | NAMS | PRVA |
|---|---|---|
| P/E ratio | N/A | 94.56 |
| Forward P/E | N/A | 79.64 |
| P/S ratio | 362.81 | 1.10 |
| P/B ratio | 4.09 | 0.00 |
Profitability
| Metric | NAMS | PRVA |
|---|---|---|
| Gross margin | 92.15% | 7.61% |
| Operating margin | -1002.90% | 1.90% |
| Net margin | -3644.21% | 1.19% |
| ROE | -41.10% | 0.00% |
| ROIC | -38.70% | 0.00% |
Growth (annualized)
| Metric | NAMS | PRVA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 22.35% |
| EPS CAGR (5Y) | N/A | -8.73% |
| Total return CAGR (5Y) | 18.30% | -1.30% |
Frequently asked
- Is NAMS or PRVA more profitable?
- PRVA runs the higher net margin — NAMS at -3644.21% versus PRVA at 1.19%.
- How have NAMS and PRVA total returns compared?
- Over the past 5 years, NAMS delivered 18.30% and PRVA delivered -1.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Privia Health P/E ratioNewAmsterdam Pharma ROEPrivia Health ROENewAmsterdam Pharma operating marginPrivia Health operating marginNewAmsterdam Pharma revenue growthPrivia Health revenue growthNewAmsterdam Pharma free cash flowPrivia Health free cash flow
NewAmsterdam Pharma & Privia Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.